VCEL
Vericel Corporation
Company Overview
| Mkt Cap | $1.60B | Price | $35.06 |
| Volume | 635.00K | Change | +1.53% |
| P/E Ratio | 154.3 | Open | $34.48 |
| Revenue | $237.2M | Prev Close | $34.53 |
| Net Income | $10.4M | 52W Range | $29.24 - $63.00 |
| Div Yield | N/A | Target | $54.29 |
| Overall | 55 | Value | 30 |
| Quality | 73 | Technical | 63 |
No chart data available
Stock Overview
Updated DailyVericel Corporation (VCEL) is a leading Healthcare company in the Biotechnology industry, currently trading at $35.06 with a market capitalization of $1.60 billion. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating strong quality characteristics with a MarketXLS quality score of 73.
Today's trading session shows VCEL with a volume of 635K shares. The stock opened down 0.14% from yesterday's close of $34.53. Current analyst estimates project earnings of $0.2 per share for this year, with next year targeting $0.6.
VCEL demonstrates positive technical signals based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including RPRX, NEOG, INIS, ICCC.
Key investment considerations for VCEL include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 54.8%. The stock shows expensive valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 01:57 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VCEL | $35.06 | +1.5% | 635.00K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |